Finance

Lists
Why is QURE down ၃.၂၉%?
Dive Deeper
QURE:NASDAQ
Uniqure NV
၂၁.၇၈ US$
-၃.၂၉%
(-၀.၇၄) 1D
၂၁.၆၅ US$
-၀.၆၀% (-၀.၁၃)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QURE...
Open
၂၂.၅၀ US$
High
၂၂.၆၈ US$
Low
၂၁.၇၀ US$
Mkt. cap
၁၅၁.၀၈ ဋေ
Avg. vol.
၂.၈၉ သန်း
Volume
၁.၂၉ သန်း
52-wk high
၇၁.၅၀ US$
52-wk low
၈.၇၃ US$
EPS
-၄.၀၅ US$
Beta
၁.၀၆
Shares outstanding
၆.၉၄ ကုဋေ
No. of employees
၂၂၁
Open
၂၂.၅၀ US$
High
၂၂.၆၈ US$
Low
၂၁.၇၀ US$
Mkt. cap
၁၅၁.၀၈ ဋေ
Avg. vol.
၂.၈၉ သန်း
Volume
၁.၂၉ သန်း
52-wk high
၇၁.၅၀ US$
52-wk low
၈.၇၃ US$
EPS
-၄.၀၅ US$
Beta
၁.၀၆
Shares outstanding
၆.၉၄ ကုဋေ
No. of employees
၂၂၁
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
UBS sets USD 48 target for uniQure stock as it trades 1.60 percent lower
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees၂၂၁
Founded၁၉၉၈
Headquarters-
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to QURE in the past 3 months
Strong buy
Buy
8
Hold
2
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for QURE in the last 3 months.
Highest
Current ၂၁.၇၈ US$
၈၀.၀၀ US$ (+၂၆၇.၃၁%)
Average
၅၃.၅၇ US$ (+၁၄၅.၉၆%)
Lowest
၂၈.၀၀ US$ (+၂၈.၅၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joon Lee
UBS
Buy
Maintained
၄၈.၀၀ US$
+၁၂၀.၄%
10/15/2026
Unknown Analyst
UBS
Buy
Initiated
၄၈.၀၀ US$
+၁၂၀.၄%
10/14/2026
Eliana Merle
Barclays
Hold
Downgraded
၂၈.၀၀ US$
+၂၈.၆%
10/06/2026
Luca Issi
RBC Capital
Buy
Reiterated
၄၈.၀၀ US$
+၁၂၀.၄%
10/02/2026
Salveen Richter
Goldman Sachs
Hold
Reiterated
၃၁.၀၀ US$
+၄၂.၃%
09/30/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
၇၅.၀၀ US$
+၂၄၄.၄%
09/29/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
၈၀.၀၀ US$
+၂၆၇.၃%
09/30/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/29/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
-
-
09/29/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
09/02/2026
Sami Corwin
William Blair
Buy
Initiated
၇၃.၀၀ US$
+၂၃၅.၂%
09/02/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
၆၈.၀၀ US$
+၂၁၂.၂%
07/29/2026
Rudy Li
Wolfe Research
Buy
Upgraded
၆၅.၀၀ US$
+၁၉၈.၄%
07/29/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
၇၀.၀၀ US$
+၂၂၁.၄%
06/17/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Upgraded
-
-
06/17/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
၃၇.၀၀ US$
+၆၉.၉%
05/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
၉၅.၀၀ US$
+၃၃၆.၂%
05/05/2026
Last report
၂၀၂၆ ဇူ ၂၉
Fiscal period
Q2 2026
-၁.၀၇ € / -၀.၇၁ €
-၅၁.၂၅%miss
Revenue / Est. (EUR)
၅.၁၃ သန်း / ၄.၃၂ သန်း
+၁၈.၆၆%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၃.၇၀ သန်း
၅.၅၇ သန်း
၃.၅၆ သန်း
၅.၈၄ သန်း
Cost of goods sold
၃.၂၂ ကုဋေ
၄.၀၂ ကုဋေ
၃.၀၇ ကုဋေ
၃.၀၇ ကုဋေ
Cost of revenue
၃.၂၂ ကုဋေ
၄.၀၂ ကုဋေ
၃.၀၇ ကုဋေ
၃.၀၇ ကုဋေ
Research and development expenses
၆.၉၅ သိန်း
-၅.၉၂ သန်း
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၉၄ ကုဋေ
၂.၁၆ ကုဋေ
၂.၀၁ ကုဋေ
၁.၉၈ ကုဋေ
Operating expense
၂.၀၇ ကုဋေ
၁.၅၆ ကုဋေ
၁.၉၉ ကုဋေ
၂.၆၁ ကုဋေ
Total operating expenses
၅.၂၉ ကုဋေ
၅.၅၇ ကုဋေ
၅.၀၆ ကုဋေ
၅.၆၈ ကုဋေ
Operating income
-၄.၉၂ ကုဋေ
-၅.၀၂ ကုဋေ
-၄.၇၁ ကုဋေ
-၅.၀၉ ကုဋေ
Other non operating income
-၇.၂၂ သန်း
၁.၈၁ ကုဋေ
၃.၇၇ သန်း
-၁.၆၀ ကုဋေ
EBT including unusual items
-၇.၁၉ ကုဋေ
-၄.၁၀ ကုဋေ
-၅.၃၀ ကုဋေ
-၇.၉၂ ကုဋေ
EBT excluding unusual items
-၇.၀၁ ကုဋေ
-၄.၀၀ ကုဋေ
-၅.၄၄ ကုဋေ
-၇.၈၀ ကုဋေ
Income tax expense
၈.၆၃ သန်း
-၃.၉၂ သန်း
၄.၈၈ သိန်း
၁.၈၄ သန်း
Effective tax rate
-၁၂.၀၀%
၉.၅၅%
-၀.၉၂%
-၂.၃၂%
Other operating expenses
၅.၃၄ သိန်း
-၁.၄၃ သိန်း
-၁.၈၁ သိန်း
၆.၃၆ သန်း
Net income
-၈.၀၅ ကုဋေ
-၃.၇၁ ကုဋေ
-၅.၃၅ ကုဋေ
-၈.၁၁ ကုဋေ
Net profit margin
-၂,၁၇၅.၈၇%
-၆၆၆.၀၆%
-၁,၅၀၂.၉၅%
-၁,၃၈၇.၇၆%
Earnings per share
-
-
-
-
Interest and investment income
၃.၅၀ သန်း
၅.၈၁ သန်း
၅.၂၃ သန်း
၅.၀၅ သန်း
Interest expense
-၁.၆၇ ကုဋေ
-၁.၄၆ ကုဋေ
-၁.၄၀ ကုဋေ
-၁.၄၄ ကုဋေ
Net interest expenses
-၁.၃၂ ကုဋေ
-၈.၇၆ သန်း
-၈.၈၀ သန်း
-၉.၃၂ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၅၆ ကုဋေ
-၄.၇၂ ကုဋေ
-၄.၄၁ ကုဋေ
-၄.၆၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ